Biobanking Market Set to Reshape the Future of Biological Sample Management

The global biobanking market is expanding as biological sample repositories become increasingly important for biomedical research, drug discovery, precision medicine, and disease investigation. Growing investments in genomics and personalized healthcare, increasing demand for high-quality biological specimens, and advancements in sample preservation technologies are supporting market development. Biobanks provide researchers and healthcare organizations with access to organized biological samples and associated data, strengthening their role in modern life sciences research.

The global biobanking market size was valued at USD 59.98 billion in 2025 and is projected to grow from USD 64.37 billion in 2026 to USD 113.27 billion by 2034, registering a CAGR of 7.32% during the forecast period from 2026 to 2034. Europe dominated the biobanking market with a market share of 36.4% in 2025, supported by established biobanking infrastructure, strong biomedical research activity, and increasing investments in precision medicine.

For detailed market insights, growth forecasts, and competitive analysis, visit: https://straitsresearch.com/report/biobanking-market

Market Drivers

Growing adoption of precision medicine

The increasing adoption of precision medicine is creating strong demand for high-quality biological samples and associated clinical data. Researchers use biobanked specimens to understand disease mechanisms, identify biomarkers, and develop therapies tailored to specific patient populations. The continued development of personalized healthcare is therefore supporting investments in biobanking infrastructure and sample management systems.

Increasing biomedical research and drug discovery

Growing research activity in genomics, molecular biology, oncology, immunology, and drug development is increasing the need for well-characterized biological specimens. Biobanks provide researchers with access to diverse samples that can support disease research, clinical studies, biomarker discovery, and therapeutic development. Increasing collaboration between research institutions, pharmaceutical companies, and healthcare organizations is further supporting market growth.

Advancements in biobanking technologies

Technological advancements in automated sample processing, cryopreservation, laboratory information management systems, and sample tracking are improving biobank efficiency. Automated storage and monitoring systems can help maintain sample integrity while reducing manual handling. The integration of digital technologies and data management platforms is also improving the organization and accessibility of biological sample information.

Market Challenges

High infrastructure and operational costs

Biobanking facilities require specialized storage systems, temperature monitoring equipment, laboratory infrastructure, security systems, and trained personnel. Maintaining samples under controlled conditions over extended periods can result in significant operational expenses. These costs may create challenges for smaller institutions and facilities with limited funding.

Complex ethical and regulatory requirements

Biobanks manage sensitive biological materials and associated health information, requiring compliance with ethical, privacy, consent, and regulatory requirements. Differences in regulations between countries and institutions can complicate sample collection, storage, sharing, and research collaboration. Maintaining appropriate governance and data protection systems is therefore essential for sustainable biobanking operations.

Sample quality and standardization challenges

Maintaining consistent sample quality throughout collection, transportation, processing, and long-term storage remains a critical challenge. Variations in collection protocols, storage conditions, and sample handling can affect specimen integrity and research outcomes. Standardized procedures and quality-control systems are increasingly important for ensuring the reliability and reproducibility of biobanking research.

Market Segmentation

By specimen type

The biobanking market can be segmented based on specimen type, including blood products, tissue samples, cell lines, nucleic acids, and other biological specimens. Different specimen types are used across research applications such as genomics, disease modeling, biomarker discovery, and drug development, supporting demand for specialized collection and storage solutions.

By type of biobank

Based on type, the market includes population-based biobanks, disease-oriented biobanks, and other specialized biobanks. Population-based facilities provide large collections for epidemiological and genomic research, while disease-oriented biobanks focus on specimens associated with specific diseases and clinical conditions.

By application

Based on application, biobanking supports research in drug discovery, genomics, regenerative medicine, disease research, clinical research, and other life sciences applications. Increasing use of biological samples in translational research and personalized medicine is expanding the application base of biobanking facilities.

By region

Geographically, the biobanking market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Europe accounted for the largest market share in 2025, while increasing investments in biomedical research, healthcare infrastructure, and genomics are supporting market development across other regions.

Regional Insights

North America

North America represents a significant market for biobanking, supported by advanced biomedical research infrastructure, strong investments in genomics, and the presence of pharmaceutical and biotechnology companies. Increasing demand for biological samples in drug discovery, clinical research, and precision medicine is contributing to regional market development.

Europe

Europe dominated the biobanking market with a 36.4% share in 2025. The region benefits from established biobank networks, strong academic and biomedical research capabilities, and increasing adoption of precision medicine. Investments in genomic research and collaborative biobanking initiatives are further supporting the regional market.

Asia Pacific

The Asia Pacific market is supported by expanding healthcare infrastructure, increasing biomedical research, growing investments in genomics, and rising demand for personalized medicine. Governments, research institutions, and life sciences companies are developing biological sample repositories to support disease research and drug development, creating opportunities for market expansion.

Key Players Analysis

The major players in the biobanking market include Thermo Fisher Scientific Inc., Brooks Life Sciences, Tecan Group Ltd., QIAGEN N.V., and Hamilton Company.

• Thermo Fisher Scientific Inc.
• Brooks Life Sciences
• Tecan Group Ltd.
• QIAGEN N.V.
• Hamilton Company

Conclusion

The biobanking market is expanding as biological sample repositories become increasingly important for precision medicine, biomedical research, genomics, and drug discovery. The market is projected to grow from USD 64.37 billion in 2026 to USD 113.27 billion by 2034 at a CAGR of 7.32%. Rising research investments, technological advancements, and increasing demand for high-quality biological specimens are expected to remain key factors supporting market growth throughout the forecast period.

About Us

Straits Research is a leading market research and intelligence organization specializing in research, analytics, and advisory services. The company provides comprehensive market reports, industry insights, and strategic business intelligence across multiple industries, helping organizations identify growth opportunities and make informed business decisions.

Contact Us

Email: [email protected]

Tel: +1 646 905 0080 (U.S.)

Tel: +44 203 695 0070 (U.K.)